MedTrace Logo

Impact of Vitamin D Supplementation on Fetomaternal Outcomes in LTBI Pregnant Females

NCT06354621 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2024-04-09

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to see the effect of vitamin D supplementation on fetomaternal outcomes in pregnant females with Latent Tuberculosis infection

The main question\[s\] it aims to answer are:

If Vitamin D supplementation has any impact on maternal outcomes. If Vitamin D supplementation has any impact on fetal outcomes.

Conditions

  • Maternal and Child Health

Interventions

DIETARY_SUPPLEMENT

Vitamin-D supplementation

Participants receiving a daily dose of vitamin D supplementation

Sponsors & Collaborators

  • University of the Punjab

    lead OTHER

Principal Investigators

  • Rubeena Zakar, PhD · University of the Punjab

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-02-28
Completion
2024-03-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06354621 on ClinicalTrials.gov